LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,662,257 | -3.1% | 590,470 | -0.4% | 0.02% | 0.0% |
| Q2 2023 | $40,935,825 | +60.3% | 593,015 | +12.0% | 0.02% | +64.3% |
| Q1 2023 | $25,537,842 | +0.6% | 529,611 | +4.1% | 0.01% | -12.5% |
| Q4 2022 | $25,380,951 | +23.8% | 508,589 | +1.1% | 0.02% | +14.3% |
| Q3 2022 | $20,501,497 | -25.2% | 503,010 | +0.9% | 0.01% | -26.3% |
| Q2 2022 | $27,391,030 | +60.0% | 498,282 | +5.8% | 0.02% | +72.7% |
| Q1 2022 | $17,116,213 | +42.4% | 471,002 | +88.5% | 0.01% | +57.1% |
| Q4 2021 | $12,022,000 | -27.8% | 249,868 | -24.1% | 0.01% | -50.0% |
| Q3 2021 | $16,653,000 | +23.2% | 329,368 | 0.0% | 0.01% | +27.3% |
| Q2 2021 | $13,521,000 | +41.5% | 329,368 | 0.0% | 0.01% | +37.5% |
| Q1 2021 | $9,558,000 | – | 329,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |